Skip to content

News

Ovarian Cancer Research Fund and National Sponsor QVC Expan...

Ovarian Cancer Research Fund and National Sponsor QVC Expand Woman to Woman Program

Gynecologic Cancer Patients to Receive New Support in Tampa, Fla. and in Stanford, Calif. WEST CHESTER, Pa (Thursday, July 11, 2013) —Ovarian Cancer Research Fund (OCRF) and QVC today announced two new Woman to Woman grant recipients, Moffitt Cancer Center in Tampa, Fla. and Stanford Women’s Cancer Center in Stanford, Calif. QVC united with OCRF … Continued

OCRA News

After Angelina: What Do You Need to Know About Ovarian and ...

After Angelina: What Do You Need to Know About Ovarian and Breast Cancer Risk?

Experts agree: “If you or a close relative has been diagnosed with ovarian cancer, speak to your doctor about getting genetic counseling.” In the wake of Angelina Jolie’s announcement that she carries a genetic mutation linked to breast and ovarian cancers, thousands of women are wondering whether they are at risk. To address their concerns, … Continued

Community

Family History of Breast Cancer but no Genetic Mutation Doe...

Family History of Breast Cancer but no Genetic Mutation Does Not Raise Risk of Ovarian Cancer

Women with a family history of breast cancer but no BRCA1/2 mutation were found to be at average risk for developing ovarian cancer. The prospective study of 8005 women from a breast cancer family history clinic found that women with a BRCA2 mutation had a 17-times higher risk of developing ovarian cancer than average, and … Continued

Research

Partner Member Profile: Feel Teal Club

Partner Member Profile: Feel Teal Club

Deb Stevens was inspired to start the Feel Teal Club “after the loss of my dear mother to the disease,” she recalls. Deb published her first book and dedicated the proceeds to cancer research. Shortly after, she says, “I joined up with an Australian based ovarian cancer network, hosting events to raise the level of … Continued

Community

Report from ASCO 2013–What's New in Ovarian Canc...

Report from ASCO 2013–What's New in Ovarian Cancer Research

We recently returned from the annual meeting of the American Society of Clinical Oncology (ASCO), an annual event that gathers thousands of cancer researchers from around the world. Many new studies on or related to ovarian cancer were presented at this year’s ASCO meeting. Click here to read a summary of ovarian cancer research from … Continued

Advocacy

Supreme Court Strikes Down BRCA Gene Patents

Supreme Court Strikes Down BRCA Gene Patents

In a unanimous ruling issued June 13, 2013, the US Supreme Court ruled that private companies do not have the right to patent human genes. In Association for Molecular Pathology et al. v. Myriad Genetics, the court considered the validity of patents held by the Utah-based company Myriad Genetics for the BRCA1 and BRCA2 genes, which … Continued

Research

June 2013 SNMMI Meeting

June 2013 SNMMI Meeting

Society for Nuclear Medicine and Molecular Imaging (SNMMI) Advocate Report from Laurel Pracht As a member of the SNMMI Advocate Advisory Board, formed in 2010 to better bridge the gap between the patient and nuclear medicine communities, I represent the ovarian patient community. Other diseases, including cancer, brain and heart disease are represented as well.  … Continued

Advocacy

Press Release: Ovarian Cancer Advocates Praise Supreme Cour...

Press Release: Ovarian Cancer Advocates Praise Supreme Court Decision on Gene Patents

Ruling Will Give Women More Options to Learn About Genetic Risk Washington, DC—The Supreme Court ruled today that a company cannot patent naturally occurring genes, including isolated gene segments, overturning a decision made by the United States Court of Appeals for the Federal Circuit in August 2012, which upheld a patent claim on the BRCA1 … Continued

Advocacy

ASCO News: Weekly Chemo Improves Quality of Life

ASCO News: Weekly Chemo Improves Quality of Life

In research presented at the American Society of Clinical Oncology meeting this week, researchers found that shortening the break between chemotherapy sessions improved quality of life for patients, without negatively impacting efficacy. Results from a randomized, phase III trial of over 800 women conducted in Italy showed that lower-dose weekly carboplatin plus paclitaxel was associated … Continued

Research

Stay Informed

Get email updates about research news, action alerts, and ways to join the fight.

We care about your data. Read our privacy policy.